Livsmed Inc (KOSDAQ:491000)

Market Cap	896.41B
Revenue (ttm)	51.72B +61.7%
Net Income	-22.46B
EPS	-979.51
Shares Out	25.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	103,054
Open	36,700
Previous Close	37,850
Day's Range	35,200 - 37,700
52-Week Range	31,550 - 95,900
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Livsmed

Livsmed Inc. engages in the research, development, manufacture, exports, and import of electro-diagnostic and electro-therapeutic apparatuses medical devices in South Korea. The company offers ArtiSential, a multi-joint articulating surgical instrument that is used for laparoscopic surgeries, as well as training kits. It exports to the Unites States, Germany, etc. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea.

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2011
• Employees: 315
• Stock Exchange: KOSDAQ
• Ticker Symbol: 491000

Financial Performance

In 2025, Livsmed's revenue was 51.19 billion, an increase of 88.75% compared to the previous year's 27.12 billion. Losses were -22.87 billion, -10.60% less than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 20, 2026

Data Sources Report a data error